375 related articles for article (PubMed ID: 36139478)
1. Elucidation of Prebiotics, Probiotics, Postbiotics, and Target from Gut Microbiota to Alleviate Obesity via Network Pharmacology Study.
Oh KK; Gupta H; Min BH; Ganesan R; Sharma SP; Won SM; Jeong JJ; Lee SB; Cha MG; Kwon GH; Jeong MK; Hyun JY; Eom JA; Park HJ; Yoon SJ; Choi MR; Kim DJ; Suk KT
Cells; 2022 Sep; 11(18):. PubMed ID: 36139478
[TBL] [Abstract][Full Text] [Related]
2. New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study.
Oh KK; Choi I; Gupta H; Raja G; Sharma SP; Won SM; Jeong JJ; Lee SB; Cha MG; Kwon GH; Jeong MK; Min BH; Hyun JY; Eom JA; Park HJ; Yoon SJ; Choi MR; Kim DJ; Suk KT
Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):1-12. PubMed ID: 36562095
[TBL] [Abstract][Full Text] [Related]
3. Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease.
Oh KK; Choi YR; Gupta H; Ganesan R; Sharma SP; Won SM; Jeong JJ; Lee SB; Cha MG; Kwon GH; Kim DJ; Suk KT
Curr Issues Mol Biol; 2022 Jul; 44(7):3253-3266. PubMed ID: 35877448
[TBL] [Abstract][Full Text] [Related]
4. The identification of metabolites from gut microbiota in NAFLD via network pharmacology.
Oh KK; Gupta H; Min BH; Ganesan R; Sharma SP; Won SM; Jeong JJ; Lee SB; Cha MG; Kwon GH; Jeong MK; Hyun JY; Eom JA; Park HJ; Yoon SJ; Choi MR; Kim DJ; Suk KT
Sci Rep; 2023 Jan; 13(1):724. PubMed ID: 36639568
[TBL] [Abstract][Full Text] [Related]
5. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
[TBL] [Abstract][Full Text] [Related]
6. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Tsigalou C; Dalamaga M
Curr Obes Rep; 2020 Sep; 9(3):179-192. PubMed ID: 32472285
[TBL] [Abstract][Full Text] [Related]
7. Prebiotics, probiotics, synbiotics and postbiotics to adolescents in metabolic syndrome.
Luzzi A; Briata IM; Di Napoli I; Giugliano S; Di Sabatino A; Rescigno M; Cena H
Clin Nutr; 2024 Jun; 43(6):1433-1446. PubMed ID: 38704983
[TBL] [Abstract][Full Text] [Related]
8. The identification of metabolites from gut microbiota in coronary heart disease via network pharmacology.
Zhou HM; Yang XY; Yue SJ; Wang WX; Zhang Q; Xu DQ; Li JJ; Tang YP
Artif Cells Nanomed Biotechnol; 2024 Dec; 52(1):145-155. PubMed ID: 38412071
[TBL] [Abstract][Full Text] [Related]
9. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking.
Wu Z; Ji X; Shan C; Song J; Zhao J
Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443
[TBL] [Abstract][Full Text] [Related]
10. The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis.
Oh KK; Gupta H; Ganesan R; Sharma SP; Won SM; Jeong JJ; Lee SB; Cha MG; Kwon GH; Jeong MK; Min BH; Hyun JY; Eom JA; Park HJ; Yoon SJ; Choi MR; Kim DJ; Suk KT
Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):217-232. PubMed ID: 37129458
[TBL] [Abstract][Full Text] [Related]
11. Probiotics, Prebiotics and Postbiotics on Mitigation of Depression Symptoms: Modulation of the Brain-Gut-Microbiome Axis.
Chudzik A; Orzyłowska A; Rola R; Stanisz GJ
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356624
[TBL] [Abstract][Full Text] [Related]
12. A Network Pharmacology and Molecular-Docking-Based Approach to Identify the Probable Targets of Short-Chain Fatty-Acid-Producing Microbial Metabolites against Kidney Cancer and Inflammation.
Karim MR; Morshed MN; Iqbal S; Mohammad S; Mathiyalagan R; Yang DC; Kim YJ; Song JH; Yang DU
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002360
[TBL] [Abstract][Full Text] [Related]
13. Identification of renal protective gut microbiome derived-metabolites in diabetic chronic kidney disease: An integrated approach using network pharmacology and molecular docking.
Saranya GR; Viswanathan P
Saudi J Biol Sci; 2024 Aug; 31(8):104028. PubMed ID: 38854894
[TBL] [Abstract][Full Text] [Related]
14. The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study.
Oh KK; Yoon SJ; Lee SB; Lee SY; Gupta H; Ganesan R; Sharma SP; Won SM; Jeong JJ; Kim DJ; Suk KT
J Transl Med; 2023 Apr; 21(1):263. PubMed ID: 37069607
[TBL] [Abstract][Full Text] [Related]
15. Review of the microbiome in skin aging and the effect of a topical prebiotic containing thermal spring water.
Woolery-Lloyd H; Andriessen A; Day D; Gonzalez N; Green L; Grice E; Henry M
J Cosmet Dermatol; 2023 Jan; 22(1):96-102. PubMed ID: 36239004
[TBL] [Abstract][Full Text] [Related]
16. Probiotics, prebiotics and amelioration of diseases.
Tsai YL; Lin TL; Chang CJ; Wu TR; Lai WF; Lu CC; Lai HC
J Biomed Sci; 2019 Jan; 26(1):3. PubMed ID: 30609922
[TBL] [Abstract][Full Text] [Related]
17. Exploring substrate-microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions.
Speckmann B; Ehring E; Hu J; Rodriguez Mateos A
Gut Microbes; 2024; 16(1):2305716. PubMed ID: 38300741
[TBL] [Abstract][Full Text] [Related]
18. Engineering the Gut Microbiome for Treatment of Obesity: A Review of Current Understanding and Progress.
Lim YY; Lee YS; Ooi DSQ
Biotechnol J; 2020 Oct; 15(10):e2000013. PubMed ID: 32663372
[TBL] [Abstract][Full Text] [Related]
19. Probiotics, prebiotics, and postbiotics in health and disease.
Ji J; Jin W; Liu SJ; Jiao Z; Li X
MedComm (2020); 2023 Dec; 4(6):e420. PubMed ID: 37929014
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota in bariatric surgery.
Gasmi A; Bjørklund G; Mujawdiya PK; Semenova Y; Dosa A; Piscopo S; Pen JJ; Gasmi Benahmed A; Costea DO
Crit Rev Food Sci Nutr; 2023; 63(28):9299-9314. PubMed ID: 35531940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
